HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

BACKGROUND: Despite a typically good response to first-line combination chemotherapy, the prognosis for patients with advanced ovarian cancer remains poor because of acquired chemoresistance. The use of targeted therapies such as trastuzumab may potentially improve outcomes for patients with ovarian...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Tuefferd, Marianne, Couturier, Jérôme, Penault-Llorca, Frédérique, Vincent-Salomon, Anne, Broët, Philippe, Guastalla, Jean-Paul, Allouache, Djelila, Combe, Martin, Weber, Béatrice, Pujade-Lauraine, Eric, Camilleri-Broët, Sophie
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2007
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2042515/
https://ncbi.nlm.nih.gov/pubmed/17987122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0001138
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items